X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Korean Company GenKOre Offering Genetic Base-Editing Tech

    Korean Company GenKOre Offering Genetic Base-Editing Tech

    Novartis to acquire The Medicines Company for USD 9.7 bn

    Beovu, Made By Novartis, Earns A Recommendation From NICE

    Lilly, AZ, AbbVie, And J&J Could Be Hurt By Medicare Bill

    Lilly, AZ, AbbVie, And J&J Could Be Hurt By Medicare Bill

    Moderna To introduce The Fusion Of COVID-19 And Flu Booster

    September May See Advent of Revised COVID-19 Booster Shots

    First Patient Adopting TAC-001 Has Been Announced By Tallac

    First Patient Adopting TAC-001 Has Been Announced By Tallac

    Arcutis Receives FDA Nod For Their Zoryve Psoriasis Cream

    Arcutis Receives FDA Nod For Their Zoryve Psoriasis Cream

    FDA Experts Recommend Changing COVID Jab Formulation In Fall

    FDA Continues To Deal With Issues With Expedited Clearance

    Test For Sterility of Cell Culture Using Ratio of NA To NAM

    Test For Sterility of Cell Culture Using Ratio of NA To NAM

    Paxlovid Allowed By FDA To Sell At Certified Pharmacies

    Pfizer Has Long-Term Plans For Paxlovid, Comirnaty, COVID-19

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Korean Company GenKOre Offering Genetic Base-Editing Tech

    Korean Company GenKOre Offering Genetic Base-Editing Tech

    Novartis to acquire The Medicines Company for USD 9.7 bn

    Beovu, Made By Novartis, Earns A Recommendation From NICE

    Lilly, AZ, AbbVie, And J&J Could Be Hurt By Medicare Bill

    Lilly, AZ, AbbVie, And J&J Could Be Hurt By Medicare Bill

    Moderna To introduce The Fusion Of COVID-19 And Flu Booster

    September May See Advent of Revised COVID-19 Booster Shots

    First Patient Adopting TAC-001 Has Been Announced By Tallac

    First Patient Adopting TAC-001 Has Been Announced By Tallac

    Arcutis Receives FDA Nod For Their Zoryve Psoriasis Cream

    Arcutis Receives FDA Nod For Their Zoryve Psoriasis Cream

    FDA Experts Recommend Changing COVID Jab Formulation In Fall

    FDA Continues To Deal With Issues With Expedited Clearance

    Test For Sterility of Cell Culture Using Ratio of NA To NAM

    Test For Sterility of Cell Culture Using Ratio of NA To NAM

    Paxlovid Allowed By FDA To Sell At Certified Pharmacies

    Pfizer Has Long-Term Plans For Paxlovid, Comirnaty, COVID-19

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

Airnov to exhibit range of healthcare packaging solutions to Indian market at Innopack Pharma Confex-South

Content Team by Content Team
1st August 2022
in Packaging & Logistic, Press Statements
Airnov to exhibit range of healthcare packaging solutions to Indian market at Innopack Pharma Confex-South

Airnov Healthcare Packaging, a global leader in controlled atmosphere packaging, will be showcasing its large portfolio of solutions available to customers in India at the upcoming Innopack Pharma Confex-South, due to be held in the city of Hyderabad on August 9-10.

The event marks an extension of the already highly successful and influential Innopack series, which is now meeting in Hyderabad to offer more industry stakeholders the chance to see and hear from the best minds on what’s next in the world of pharma packaging.

Here, Airnov will be demonstrating a range of value-add capabilities.

Chief among them is Stablus, a predictive modelling and simulation tool. Stablus helps customers determine optimal solutions for shelf-life protection within key cost parameters.

Airnov’s line of desiccant canisters and packets are designed for high-speed automatic insertion in customers’ packaging lines. This ensures seamless integration with existing manufacturing setups, with our engineers also on hand to provide technical support when needed.

The company will also be showing visitors at Innopack Pharma Confex-South, the Compatilus program, which ensures full compatibility with various automatic desiccant inserters for drop-in desiccants available from key equipment manufacturers.

By evaluating how packaging configurations impacts relative humidity levels and/ oxygen concentrations inside packaging across its lifecycle, customers will be able to identify technical and cost-saving improvements and reduce time to market for new products.

Airnov will also be showcasing a series of physical pioneering packaging solutions. These include EQius™ Equilibrium RH Stabilizers – these are sorbent products that maintain a certain humidity level in pharmaceutical packaging in cases where specific relative humidity conditions are required. In particular, these are solutions aimed at dry powder inhalers, gelatin capsules and gummies.

Shrikar Trikannad, Airnov’s Head of Sales for India, commented: “After a successful Innopack event in Mumbai in June, we are equally excited to head to Hyderabad, where our highly experienced team will be on hand and ready to answer any questions about any of our solutions and services.”

Visitors will also be able to learn more about our product development and innovation workshops. Whether it’s tweaking a standard product or developing a design for a customized packaging system, Airnov has a full product development team that will quickly and efficiently engineer a solution.

“With a 65-year legacy to build on and three dedicated R&D centers, we remain at the forefront of research into materials and designs that will shape the future of healthcare packaging” concludes Trikannad.

During the Innopack Pharma Confex-South, which is being hosted at the Novotel HICC, Airnov will be situated in Booth 2A.

Previous Post

NHS Lays Long COVID Action Plan For Many With Chronic Signs

Next Post

Authorities Agree To Work Together Towards Integrating RWE

Related Posts

EMA Advises Recall of AbbVie, Biogen MS Drug
Middle East and South Asia

With $6.26bn In Q1, The Indian Pharma Exports Grew By 8%

3rd August 2022
BioMed X Institute and Healthcare Business of Merck KGaA, Darmstadt, Germany, Start New Research Project in Oncology
Press Statements

BioMed X Institute and Healthcare Business of Merck KGaA, Darmstadt, Germany, Start New Research Project in Oncology

1st August 2022
Shimadzu's Nexera XS Inert Chromatography System Enhances Biopharma Analysis
IPR Data Management

Shimadzu’s Nexera XS Inert Chromatography System Enhances Biopharma Analysis

28th July 2022
Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer
Drug Development

Roche Launches Dual Antigen and Antibody Hepatitis C Diagnostic Test

27th July 2022
Merck and Orion Announce Global Collaboration for Oncology Drug
Drug Development

Merck and Orion Announce Global Collaboration for Oncology Drug

26th July 2022
Grünenthal to buy NebidoTM testosterone treatment from Bayer for €500m
Market Moves

Grünenthal to buy NebidoTM testosterone treatment from Bayer for €500m

18th July 2022
Next Post
Authorities Agree To Work Together Towards Integrating RWE

Authorities Agree To Work Together Towards Integrating RWE

Latest News

EMA Advises Recall of AbbVie, Biogen MS Drug
Middle East and South Asia

With $6.26bn In Q1, The Indian Pharma Exports Grew By 8%

3rd August 2022
Big Data Steering Group To Better Data Effectiveness, Search
IPR Data Management

Big Data Steering Group To Better Data Effectiveness, Search

3rd August 2022
Europe To Obtain 85 Million Pandemic Flu Vaccines From GSK
Facilities & Operation

Europe To Obtain 85 Million Pandemic Flu Vaccines From GSK

3rd August 2022
Korean Company GenKOre Offering Genetic Base-Editing Tech
News

Korean Company GenKOre Offering Genetic Base-Editing Tech

3rd August 2022
Novartis to acquire The Medicines Company for USD 9.7 bn
FDA Approvals

Beovu, Made By Novartis, Earns A Recommendation From NICE

2nd August 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In